Conclusion Sermorelin has been widely investigated as a GHRH analog that may engage endocrine pathways with potential implications for growth hormone signaling, cardiovascular physiology, neurological regulation, and tissue structure
There is some concern, however, that, while weight loss in obese patients with asthma is associated with improvements in level of lung function and airway responsiveness to inhaled methacholine [61], no significant improvements have been observed in exhaled nitric oxide [62] or other markers of eosinophilic airway inflammation [63]
Never Double-Dose : Taking two doses to catch up increases side effect risks
Mech Ageing Dev 2001;122:4168
Phase II Jastreboff 2023 NEJM : -24,2% 12mg/48sem pour retatrutide vs SURMOUNT-1 Jastreboff 2022 : -20,9% 15mg/72sem pour tirzepatide
So how are people accessing it